Loading insider details...
Beta
Latest Form 4 (Sep 3, 2026): Disposition to Issuer of 158,371 APGE shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 3, 2026 | Apogee Therapeutics, Inc. (APGE) | Disposition to Issuer | 158,371 | n/a |
| Jul 25, 2026 | Apogee Therapeutics, Inc. (APGE) | Gift | 15,000 | n/a |
| May 5, 2026 | Apogee Therapeutics, Inc. (APGE) | Sale | 811 | $65.7K |
| Apr 18, 2026 | Apogee Therapeutics, Inc. (APGE) | Sale | 2,000 | $180.0K |
| Apr 4, 2026 | Apogee Therapeutics, Inc. (APGE) | Sale | 900 | $76.0K |
| Mar 28, 2026 | Apogee Therapeutics, Inc. (APGE) | Sale | 2,000 | $170.0K |
| Mar 5, 2026 | Apogee Therapeutics, Inc. (APGE) | Sale | 300 | $20.5K |
| Feb 5, 2026 | Apogee Therapeutics, Inc. (APGE) | Sale | 792 | $51.6K |
| Jan 7, 2026 | Apogee Therapeutics, Inc. (APGE) | Sale | 1,920 | $142.3K |
| Dec 24, 2025 | Apogee Therapeutics, Inc. (APGE) | Sale | 1,500 | $120.0K |